Onco-NX Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Investors
-
1
Onco-NX General Information
Description
Operator of a drug development company headquartered in Manchester, England. The company engages in the development of drugs and medicines to detect cancerous tumor cells.
Contact Information
Website
www.onco-nx.comCorporate Office
- Incanthera Limited
- 76 King Street
- Manchester M2 4NH
- England, United Kingdom
Corporate Office
- Incanthera Limited
- 76 King Street
- Manchester M2 4NH
- England, United Kingdom
Onco-NX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 11-Mar-2014 | Completed | Startup | |||
| 2. Early Stage VC | 09-Nov-2011 | Completed | Startup | |||
| 1. University Spin-Out | 07-Apr-2011 | Completed | Startup |
Onco-NX Patents
Onco-NX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2662917-T3 | Quinone compounds and their uses for cancer treatment | Active | 30-Jul-2012 | ||
| AU-2013298653-A1 | Quinone compounds and their uses for the treatment of cancer | Active | 30-Jul-2012 | ||
| AU-2013298653-B2 | Quinone compounds and their uses for the treatment of cancer | Inactive | 30-Jul-2012 | ||
| CA-2880021-A1 | Quinone compounds and their uses for the treatment of cancer | Active | 30-Jul-2012 | ||
| EP-2882743-A1 | Quinone compounds and their uses for the treatment of cancer | Active | 30-Jul-2012 | C07D203/14 |
Onco-NX Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Spark Impact | Corporate Venture Capital | Minority |
Onco-NX FAQs
-
When was Onco-NX founded?
Onco-NX was founded in 2011.
-
Where is Onco-NX headquartered?
Onco-NX is headquartered in Manchester, United Kingdom.
-
What industry is Onco-NX in?
Onco-NX’s primary industry is Drug Discovery.
-
Is Onco-NX a private or public company?
Onco-NX is a Private company.
-
What is Onco-NX’s current revenue?
The current revenue for Onco-NX is .
-
How much funding has Onco-NX raised over time?
Onco-NX has raised $79.6K.
-
Who are Onco-NX’s investors?
Spark Impact has invested in Onco-NX.
-
When was Onco-NX acquired?
Onco-NX was acquired on 11-Mar-2014.
-
Who acquired Onco-NX?
Onco-NX was acquired by Incanthera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process